Ongoing Studies
A. Drug Standardization
Aims and Objectives:
{C}i. To lay down Pharmacopoeia standards for identity, purity, quality, safety and therapeutic efficacy in terms of Pharmacognostical, Physico-chemical and Pharmacological profiles of raw as well as finished products of homoeopathic drugs.
{C}ii. To propagate/disseminate the research findings through publication of Reports, Scientific articles, Monographs and Books etc.
The study of “Drug Standardization” is meant for Pharmacognostical, Physico-chemical and Pharmacological profiles of drug and one of most fundamental prerequisites study for introduction of new drug or formulation in clinical practice. In medical science, drug standardization study plays major role to ensure genuineness, purity, quality, safety and efficacy of the medicine before clinical trial in human.
In homoeopathy, Pharmacognostical study helps in proper identification/authentication of genuine drug from its adulterant by undertaking macro and microscopic study of plant parts and powders which are used for preparation of homoeopathic drugs. Physico-chemical study ensures purity and quality of active ingredients of drug whereas Pharmacological study ensures side/adverse/toxic effects of the drug and helps to standardize the therapeutic and lethal dose of drug in laboratory animals before the drug is subjected for clinical trials in human being.
At present this institute conducts only Pharmacognostical & Physico-chemical aspects whereas Pharmacological study will be initiated soon in newly established animal house.
Existing Infrastructure:
{C}1. {C}Pharmacognosy laboratory
{C}2. {C}Physico-chemical Laboratory
{C}3. {C}Pharmacology Laboratory
{C}4. {C}In-house Pharmacy
{C}5. {C}Molecular-biology Laboratory (under development)
{C}6. {C}Raw Drug Museum
{C}7. {C}Medicinal Plants Garden
{C}8. {C}Repository Work
{C}9. {C}Zebrafish Laboratory
{C}10. Animal House
i. Drug standardization program ongoing studies:
{C}1. {C}Standardization work of allotted plants and chemicals.
{C}2. {C}Revision / Updation of different volumes of HPI.
{C}3. {C}Preparation of Monograph for HPI Vol. XI.
{C}4. {C}In-vitro & In-vivo Antifungal activity of Homoeopathic medicine & their effect on Fungal Cell Wall integrity.
{C}5. {C}Embryo toxicity of Homoeopathic medicine in Zebrafish Embryos.
ii. Other establishment
{C}1. {C}CPCSEA registration of Animal House in October, 2018.
B. Drug Proving
The very foundation of homoeopathy is based on the action of drug substances on the living systems. The earliest experiments conducted in homoeopathy were those of Drug Proving on human beings. Trials conducted on healthy human beings elicit the finer symptoms of the drug as compared to the gross toxicological symptoms evident from animal studies. These more subtle subjective and objective symptoms form the profile of the drug recorded further in the Homoeopathic MateriaMedica.
The institute conducts drug proving to record the signs and symptoms of coded drugs on healthy volunteers, in collaboration with various Homoepathic Medical Colleges. At present, the study is being conducted in collaboration with Nehru Homoeopathic Medical college and hospital, New Delhi and will also initiate the study with Bakson Homoeopathic Medical College & Hospital, Greater Noida and Dr. B. R. Sur Homoeopathic Medical College & Hospital, New Delhi. So far, 31 drugs have been proved under this programme by the Institute.
Code No. of Drugs under proving:
{C}1. 13113 (2017-18)
{C}2. 13213 (2017-18)
DRUG PROVING NODAL OFFICE
Till June 2014, the coding of the medicines was being done at the CCRH headquarters and now with change of the nodal office of multicentric study of Drug Proving to DDPRCRI (H), Noida this is being done at this Institute only. The coded drugs are given to the volunteers, as per standard protocol. Both the prover and the proving master are unaware of the medicine being proven (Double Blind Method).
DDPRCRI(H) is Nodal office for Drug Proving Research Programme and the following institutes/units are the drug proving centers:
{C}· DDPRCRIH, Noida
{C}· CRI (H), Kottayam
{C}· HDRI, Lucknow
{C}· DAC RRI(H), Kolkata
{C}· RRI (H), Gudivada
{C}· DPU, Bhubaneswar
{C}· RRI (H), Navi Mumbai
{C}· RRI (H), Jaipur
Since inception the Council has proved 111 drugs till date. The details with regard to the names of the drugs, year of research trial and publication status is available at the main website of the Council (www.ccrhindia.nic.in).
C. Clinical Verification
Homoeopathic Materia Medica is built upon signs and symptoms produced during proving of the drug on healthy human volunteers, toxic effects as observed during accidental poisoning or prolonged use of the drug, and clinical symptoms (observed to disappear while drug is administered to sick person). The symptomatic data need to be clinically verified on sick persons for their prescribing value before it is included in the Homoeopathic Materia Medica, which forms the basis of clinical prescription of the respective drug(s) on sick. So far, 73 drugs have been verified and study of 08 drugs is going on.
Ongoing studies on following drugs:
|
S. No.
|
Name of the drugs
|
Period of verification
|
|
{C}1.
|
Acorus calamus
|
on-going (initiated in 2018)
|
|
{C}2.
|
Apium graveolens
|
on-going (initiated in 2018)
|
|
{C}3.
|
Brassica oleracia
|
on-going (initiated in 2018)
|
|
{C}4.
|
Cochlearia arborea
|
on-going (initiated in 2018)
|
|
{C}5.
|
Datura arborea
|
on-going (initiated in 2018)
|
|
{C}6.
|
Datura metel
|
on-going (initiated in 2018)
|
|
{C}7.
|
Leucas aspera
|
on-going (initiated in 2018)
|
|
{C}8.
|
Withania somnifera
|
on-going (initiated in 2018)
|
D. Clinical Research
To trace out a set of efficacious medicines in various disease conditions and to study the role of a particular drug in a disease condition clinical research is being carried out based on recent medical parameters. The institute has conducted several clinical research studies and as per the assignments randomized controlled trials are being taken up in the research areas of National importance. Special days are assigned to each doctor/investigator for enrolment/screening/follow up of the research cases, in addition to their regular general OPD/IPD duties.
Ongoing:
Observational studies:
{C}· Vitiligo:Observational study to evaluate response to homoeopathic treatment in vitiligo(Project initiated in April 2015)
{C}· Susceptibility: Questionnaire for assessment of susceptibility study (Project initiated in October, 2018)
{C}· Rheumatoid arthritis: Management of Rheumatoid arthritis with individualised homoeopathy: an observational study (Project initiated in June 2018)
{C}· Adenotonsillar hypertrophy: Homoeopathic management of symptomatic adenotonsillar hypertrophy in children: a prospective observational study. (Project initiated in June 2018)
{C}· Psoriasis:Observational study to evaluate homoeopathic treatment in Psoriasis: Project initiated in Nov, 2014)
Randomized Controlled Trails (RCTs) are in progress on following clinical research studies –
{C}· Iron Deficiency Anaemia in Children:Homoeopathic Ferrum Drugs in Treatment of Iron Deficiency Anaemia in Children. (Projects initiated in September, 2015 )
{C}· Knee Osteoarthritis: Comparing individualized homoeopathic with placebo in managing pain of knee osteoarthritis a double blind randomized controlled trial: ( Project initiated in April, 2014)
{C}· Wart: Double blind controlled study to evaluate the efficacy of predefined homoeopathic medicines in treatment of warts.
{C}· Low back pain:Management of chronic non specific low back pain (NSLBP) with homoeopathic intervention versus placebo along with directional preference exercise – a parallel arm randomised controlled pilot study
Drug Validation studies:
{C}· Drug Validation:Drug Validation of Homoeopathic drugs for Bronchial Asthma(Project initiated in November,2016 )
{C}· Drug Validation:Prognostic factor research of symptoms indicating homoeopathic medicine for cough trial(Project initiated in May 2018 )
{C}· Muriatic family:Prevalence of selected objective signs of the Muriatic family of homoeopathic medicines(Project initiated in November, 2017)
Concluded Studies
C}{C}· {C} Research Areas
A. Drug Standardization
Aims and Objectives:
{C}{C}i. {C}To lay down Pharmacopoeia standards for identity, purity, quality, safety and therapeutic efficacy in terms of Pharmacognostical, Physico-chemical and Pharmacological profiles of raw as well as finished products of homoeopathic drugs.
{C}{C}ii. {C}To propagate/disseminate the research findings through publication of Reports, Scientific articles, Monographs and Books etc.
The study of “Drug Standardization” is meant for Pharmacognostical, Physico-chemical and Pharmacological profiles of drug and one of most fundamental prerequisites study for introduction of new drug or formulation in clinical practice. In medical science, drug standardization study plays major role to ensure genuineness, purity, quality, safety and efficacy of the medicine before clinical trial in human.
In homoeopathy, Pharmacognostical study helps in proper identification/authentication of genuine drug from its adulterant by undertaking macro and microscopic study of plant parts and powders which are used for preparation of homoeopathic drugs. Physico-chemical study ensures purity and quality of active ingredients of drug whereas Pharmacological study ensures side/adverse/toxic effects of the drug and helps to standardize the therapeutic and lethal dose of drug in laboratory animals before the drug is subjected for clinical trials in human being.
At present this institute conducts only Pharmacognostical & Physico-chemical aspects whereas Pharmacological study will be initiated soon in newly established animal house.
Existing Infrastructure:
{C}{C}1. {C}{C}Pharmacognosy laboratory
{C}{C}2. {C}{C}Physico-chemical Laboratory
{C}{C}3. {C}{C}Pharmacology Laboratory
{C}{C}4. {C}{C}In-house Pharmacy
{C}{C}5. {C}{C}Molecular-biology Laboratory (under development)
{C}{C}6. {C}{C}Raw Drug Museum
{C}{C}7. {C}{C}Medicinal Plants Garden
{C}{C}8. {C}{C}Repository Work
{C}{C}9. {C}{C}Zebrafish Laboratory
{C}{C}10. {C}Animal House
i. Drug standardization program ongoing studies:
{C}{C}1. {C}{C}Standardization work of allotted plants and chemicals.
{C}{C}2. {C}{C}Revision / Updation of different volumes of HPI.
{C}{C}3. {C}{C}Preparation of Monograph for HPI Vol. XI.
{C}{C}4. {C}{C}In-vitro & In-vivo Antifungal activity of Homoeopathic medicine & their effect on Fungal Cell Wall integrity.
{C}{C}5. {C}{C}Embryo toxicity of Homoeopathic medicine in Zebrafish Embryos.
ii. Other establishment
{C}{C}1. {C}CPCSEA registration of Animal House in October, 2018.
B. Drug Proving
The very foundation of homoeopathy is based on the action of drug substances on the living systems. The earliest experiments conducted in homoeopathy were those of Drug Proving on human beings. Trials conducted on healthy human beings elicit the finer symptoms of the drug as compared to the gross toxicological symptoms evident from animal studies. These more subtle subjective and objective symptoms form the profile of the drug recorded further in the Homoeopathic MateriaMedica.
The institute conducts drug proving to record the signs and symptoms of coded drugs on healthy volunteers, in collaboration with various Homoepathic Medical Colleges. At present, the study is being conducted in collaboration with Nehru Homoeopathic Medical college and hospital, New Delhi and will also initiate the study with Bakson Homoeopathic Medical College & Hospital, Greater Noida and Dr. B. R. Sur Homoeopathic Medical College & Hospital, New Delhi. So far, 31 drugs have been proved under this programme by the Institute.
Code No. of Drugs under proving:
{C}{C}1. {C}13113 (2017-18)
{C}{C}2. {C}13213 (2017-18)
DRUG PROVING NODAL OFFICE
Till June 2014, the coding of the medicines was being done at the CCRH headquarters and now with change of the nodal office of multicentric study of Drug Proving to DDPRCRI (H), Noida this is being done at this Institute only. The coded drugs are given to the volunteers, as per standard protocol. Both the prover and the proving master are unaware of the medicine being proven (Double Blind Method).
DDPRCRI(H) is Nodal office for Drug Proving Research Programme and the following institutes/units are the drug proving centers:
{C}{C}· {C}DDPRCRIH, Noida
{C}{C}· {C}CRI (H), Kottayam
{C}{C}· {C}HDRI, Lucknow
{C}{C}· {C}DAC RRI(H), Kolkata
{C}{C}· {C}RRI (H), Gudivada
{C}{C}· {C}DPU, Bhubaneswar
{C}{C}· {C}RRI (H), Navi Mumbai
{C}{C}· {C}RRI (H), Jaipur
Since inception the Council has proved 111 drugs till date. The details with regard to the names of the drugs, year of research trial and publication status is available at the main website of the Council (www.ccrhindia.nic.in).
C. Clinical Verification
Homoeopathic Materia Medica is built upon signs and symptoms produced during proving of the drug on healthy human volunteers, toxic effects as observed during accidental poisoning or prolonged use of the drug, and clinical symptoms (observed to disappear while drug is administered to sick person). The symptomatic data need to be clinically verified on sick persons for their prescribing value before it is included in the Homoeopathic Materia Medica, which forms the basis of clinical prescription of the respective drug(s) on sick. So far, 73 drugs have been verified and study of 08 drugs is going on.
Ongoing studies on following drugs:
|
S. No.
|
Name of the drugs
|
Period of verification
|
|
{C}{C}1.{C}{C}
|
Acorus calamus
|
on-going (initiated in 2018)
|
|
{C}{C}2.{C}{C}
|
Apium graveolens
|
on-going (initiated in 2018)
|
|
{C}{C}3.{C}{C}
|
Brassica oleracia
|
on-going (initiated in 2018)
|
|
{C}{C}4.{C}{C}
|
Cochlearia arborea
|
on-going (initiated in 2018)
|
|
{C}{C}5.{C}{C}
|
Datura arborea
|
on-going (initiated in 2018)
|
|
{C}{C}6.{C}{C}
|
Datura metel
|
on-going (initiated in 2018)
|
|
{C}{C}7.{C}{C}
|
Leucas aspera
|
on-going (initiated in 2018)
|
|
{C}{C}8.{C}{C}
|
Withania somnifera
|
on-going (initiated in 2018)
|
D. Clinical Research
To trace out a set of efficacious medicines in various disease conditions and to study the role of a particular drug in a disease condition clinical research is being carried out based on recent medical parameters. The institute has conducted several clinical research studies and as per the assignments randomized controlled trials are being taken up in the research areas of National importance. Special days are assigned to each doctor/investigator for enrolment/screening/follow up of the research cases, in addition to their regular general OPD/IPD duties.
Ongoing:
Observational studies:
{C}{C}· {C}Vitiligo:Observational study to evaluate response to homoeopathic treatment in vitiligo(Project initiated in April 2015)
{C}{C}· {C}Susceptibility: Questionnaire for assessment of susceptibility study (Project initiated in October, 2018)
{C}{C}· {C}Rheumatoid arthritis: Management of Rheumatoid arthritis with individualised homoeopathy: an observational study (Project initiated in June 2018)
{C}{C}· {C}Adenotonsillar hypertrophy: Homoeopathic management of symptomatic adenotonsillar hypertrophy in children: a prospective observational study. (Project initiated in June 2018)
{C}{C}· {C}Psoriasis:Observational study to evaluate homoeopathic treatment in Psoriasis: Project initiated in Nov, 2014)
Randomized Controlled Trails (RCTs) are in progress on following clinical research studies –
{C}{C}· {C}Iron Deficiency Anaemia in Children:Homoeopathic Ferrum Drugs in Treatment of Iron Deficiency Anaemia in Children. (Projects initiated in September, 2015 )
{C}{C}· {C}Knee Osteoarthritis: Comparing individualized homoeopathic with placebo in managing pain of knee osteoarthritis a double blind randomized controlled trial: ( Project initiated in April, 2014)
{C}{C}· {C}Wart: Double blind controlled study to evaluate the efficacy of predefined homoeopathic medicines in treatment of warts.
{C}{C}· {C}Low back pain:Management of chronic non specific low back pain (NSLBP) with homoeopathic intervention versus placebo along with directional preference exercise – a parallel arm randomised controlled pilot study
Drug Validation studies:
{C}{C}· {C}Drug Validation:Drug Validation of Homoeopathic drugs for Bronchial Asthma(Project initiated in November,2016 )
{C}{C}· {C}Drug Validation:Prognostic factor research of symptoms indicating homoeopathic medicine for cough trial(Project initiated in May 2018 )
{C}{C}· {C}Muriatic family:Prevalence of selected objective signs of the Muriatic family of homoeopathic medicines(Project initiated in November, 2017)
Concluded Studies:
{C}{C}i){C} Drug Standardization
Pharmacognostic and/or Physico-chemical studies on following drugs have been concluded ( ) under drug standardization program since inception i.e.May’2007 to till date:
|
S. No.
|
Name of drug
|
Part used
|
Pharmacognostical study
|
Physico-chemical study
|
|
*1.
|
Lactucasativa
|
Leaf
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*2.
|
Venoniaanthelmintica
|
Seed
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*3.
|
Bellisperennis
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*4.
|
Pastinacasativa
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*5.
|
Cuscutareflexa
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*6.
|
Coleus aromaticus
|
Leaf
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*7.
|
Glycirrhizaglabra
|
Rhizome
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*8.
|
Ocimum sanctum
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*9.
|
Calotropisgigantia
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*10.
|
Symplocosracemosa
|
Bark
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*11.
|
Syzygiumjambolanum
|
Seed
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*13.
|
Merremiaturpethum
|
Rhizome
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
#14
|
Magnesia sulph
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
|
*15
|
Atista radix
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*16
|
Blumealacera
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*17
|
Buxussempervirens
|
Leaf
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*18
|
Coleus forskohlii
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
#19
|
Cuprum oxydatumnigrum
|
Chemical
|
-
|
{C}{C}ü {C}{C}
|
|
*20
|
Ammivisnaga
|
Fruit
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*21
|
Pimentaofficinalis
|
Fruit
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*22
|
Amoorarohituka
|
Stem bark
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*23
|
Corchoruscapsularis
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*24
|
Gossypiumherbaceum
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*25
|
Cephalisipecacuhana
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
#26
|
Acid butyricum
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
|
*27
|
Amygdaluspersica
|
Flower
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*28
|
Coffeatosta
|
Roasted seed
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*29
|
Ficuscarica
|
Fruit
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*30
|
Heliotropium
peruvianum
|
Leaf, stem
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*31
|
Pyrusmalus
|
Leaf, stem
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*32
|
Rosamarinusofficinalis
|
Leaf
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
#33
|
Urea pura
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
|
#34
|
Methylene blue
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
|
*35
|
Cupressuslawsoniana
|
Twig and berries
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*36
|
Daturaferox
|
Seed
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*37
|
Juniperusvirginiana
|
Twig
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*38
|
Mallotusphilippensis
|
Red powder of fruits
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*39
|
Mercuriussulphuricus
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
|
*40
|
Merremiaturpethum
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*41
|
Plectranthusfruticosus
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
#2
|
Plumbumiodatum
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
|
*43
|
Bryophyllumcalycinum
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*44
|
Commiphoraweightii
|
Resin
|
--
|
{C}{C}ü {C}{C}
|
|
*45
|
Erigeron canadensis
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*46
|
Juniperuscommunis
|
Berry
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*47
|
Lobelia erinus
|
Whole plant
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*48
|
Manihotesculenta
|
Tuber
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
*49
|
Rumexcrispus
|
Root
|
{C}{C}ü {C}{C}
|
{C}{C}ü {C}{C}
|
|
#50
|
Magnesium fluoratum
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
|
#51
|
Mentholum
|
Chemical
|
--
|
{C}{C}ü {C}{C}
|
| |
Cocculusindicus
|
Seeds
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Coffeacruda
|
Seeds
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Marsdeniacundurango(cundurango)
|
Bark
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Ficusindica
|
Hanging aerial roots
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Hygrophilaspinosa
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Brynopsislaciniosa
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Bryophllumcalycinum
|
Leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Daturaferox
|
Seeds
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Ephedra vulgaris
|
Stem
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Ficuscarica
|
unripe fruit and milky juice
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Lobelliaerinus
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Plectranthusfruticosus
|
Whole plant (tincture of fresh plant)
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Pyrusmalus
|
leaves and young stem
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Quassiaamara
|
Woods
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Rosa damascena
|
Flower twigs
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Adansoniadigitata
|
Leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Dolichospruriens
|
The hair carefully scraped from the epidermis of pod
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Carapicheaipecacuanha (Ipecauanha)
|
Roots
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Pilocarpuspennatifolius (Jabrondi)
|
Leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Janosiaasoka
|
Bark
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Cephalandraindica
|
Leaf
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Cinchona officinalis
|
Bark
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Curcuma longa
|
Rhizome
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Erigeron canadensis
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Gymnemasylvestre
|
Leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Holarrhoenaantidysenterica
|
Dried bark
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Hydrocotyleasiatica
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Justiciaadhatoda
|
Leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Abromaaugusta
|
Leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Croton tiglium
|
Oil from seeds
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Erigeron candensis
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Eucalyptus globulus
|
Leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Ficusreligiosa
|
Tender leaves
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Couniummaculatum
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Lathyrussativus
|
Seeds
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Lucas aspera
|
Whole plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Salvia sclarea
|
Aerial part (Flowering tops & leaves )
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
| |
Commiphorawightii
|
flowering plant
|
{C}{C}ü {C}
|
{C}{C}ü {C}
|
* Drug of plant origin
# Drug of chemical origin
3 Antifungal + 3 Antibacterial Study
Pharmacological and Microbiological studies concluded are as mentioned below:
1. Evaluation of antifungal activity of different homoeopathic mother tinctures against Candida albicans. Indian J Res Homoeopathy 2017;11:237-43.
2. Morphological Characterization of Homeopathic Medicinal Plants and Evaluation of their Biological Effect Against the “Microsporumcanis”. Under process for publication.
3. Assessment of Biological effect of Homeopathic drugs and their ultrahigh dilution potencies against Aspergillus niger In vitro. Under process for publication.
4. Anti bacterial effect of some homeopathic mother tinctures and their potencies against E. coli bacterial strain. Data not published yet.
5. Anti bacterial effect of some homeopathic mother tinctures and their potencies against Klebsiella pneumonia bacterial strain. Data not published yet.
6. Anti bacterial effect of some homeopathic mother tinctures and their potencies against P. mirabilis bacterial strain. Data not published yet.
{C}{C}ii){C} Concluded Studies under Drug Proving Programme
Code No. of Drugs Proved so far:-
{C}{C}1. {C}8413 {Achorus calamus} (2008-09)
{C}{C}2. {C}9213 {Cynara scolumus) (2009-10)
{C}{C}3. {C}9513 {Foeniculum vulgaris} (2009-10)
{C}{C}4. {C}10213 {Cyclosporin} (2009-10)
{C}{C}5. {C}9713 {Hygrophilla spinosa} (2010-11)
{C}{C}6. {C}9813 {Mangnolia grandiflora}(2010-11)
{C}{C}7. {C}10313 { Azathioprine}(2010-11)
{C}{C}8. {C}10413 {Allium sativum} (2011-12)
{C}{C}9. {C}10513 {Apium graveolens}(2011-12)
{C}{C}10. {C}10613 { Avena sativa}(2011-12)
{C}{C}11. {C}8613{Leucas aspera} (2012-13)
{C}{C}12. {C}9313 {Dhatura arborea}(2012-13)
{C}{C}13. {C}9413 {Datura metal}(2012-13)
{C}{C}14. {C}10113 {Withania somnifera}(2012-13)
{C}{C}15. {C}11313 {Brassica oleracea} (2013-14)
{C}{C}16. {C}11513 {Ephedra vulgaris} (2013-14)
{C}{C}17. {C}11613 {Ferrum pic} (2013-14)
{C}{C}18. {C}11713 {Jalapa} (2013-14)
{C}{C}19. {C}11813 {Syzigium jambolin} (2013-14)
{C}{C}20. {C}12013 (2013-14)
{C}{C}21. {C}11413 {Anthrakokali} (2014-15)
{C}{C}22. {C}12113 {Blatta orientalis} (2014-15)
{C}{C}23. {C}12213 {Cuprum aceticum}(2014-15)
{C}{C}24. {C}12413 (2015-16)
{C}{C}25. {C}12813 {Solanum xanthocarpum} (2015-16)
{C}{C}26. {C}12313 {Gallicum acidum} (2015-16)
{C}{C}27. {C}11013 {Damiana} (2015-16)
{C}{C}28. {C}12713 (2016-17)
{C}{C}29. {C}12913 (2016-17)
Note:For few of the drugs the names are not yet revealed as the study has not been completed at other centers or has been subjected to reproving due to paucity of symptoms generated in the trial.
{C}{C}iii){C} Concluded Studies under Clinical Verification
|
CV project No.
|
Name of the drugs
|
Period of verification
|
Publication
|
|
1.
|
1. Acalypha indica
2. Acid butyricum
3. Alfalfa
4. Aranea diadema
5. Aranea scinencia
6. Arsenicum bromatum
7. Azadirachta indica
8. Bellis perennis
9. Calotropis gigantean
10. Cassia fistula
11. Chromium kali sulphuricum
12. Curcuma longa
13. Cynodon dactylon
14. Euphorbia lathyris
15. Glycyrrhiza glabra
16. Holarrhena antidysenterica
17. Ichthyolum
18. Lapis albus
19. Magnesia sulphurica
20. Mangifera indica
21. Mygale lasiodora
22. Ocimum canum
23. Oxytropis lamberti
24. Pyrus americana
25. Rauwolfia serpentine
26. Ricinus communis
27. Staphylococcinum
28. Tribulus terrestris
29. Tarentula cubensis
30. Tela aranea
31. Terminalia arjuna
32. Thea chinensis
33. Theridion curassavicum
34. Tylophora indica
|
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
2007-2010
|
-Published in CV materia medica vol III, published as monograph.
-Published in CV materia medica vol III.
-Published in CV materia medica vol.III, and as journal article in IJRH.
-Published in CV materia medica vol III
-Published in CV materia medica vol.III.
-Published in CV materia medica vol III.
To be published in CV materia medica vol. IV.
-Published in CV materia medica vol III
-Published in CV materia medica vol III
Published in CV materia medica vol III, as journal article in IJRH.
-Published in CV materia medica vol III
-Published in CV materia medica vol III, and as journal article in IJRH.
-Published as monograph.
-Published in CV materia medica vol III
-Published in CV materia medica vol III, and as journal article in IJRH.
-Published in CV materia medica vol III, and as journal article in IJRH.
-Published in CV materia medica vol III, and as a journal article in IJRH.
-Published in CV materia medica vol III
-Published in CV materia medica vol III
-Published in CV materia medica vol III
-Published in CV materia medica vol III, and as a journal article in IJRH.
-Published in CV materia medica vol III, and as a journal article in IJRH.
-Published as a monograph.
-To be published in CV materia medica vol. IV.
To be published in CV Materia Medica Vol. IV
To be published in CV materia medica vol. IV.
To be published in CV materia medica vol. IV.
To be published in CV materia medica vol. IV.
Published as journal article in IJRH.
To be published in CV Materia Medica Vol. IV
To be published in CV materia medica vol. IV.
To be published in CV Materia Medica Vol. IV
Published in CV Materia Medica Vol. I
Published as Monograph
QB Vol. 25 (1&2), 2003, pp. 33-35
To be published in CV Materia Medica Vol. IV
To be published in CV Materia Medica Vol. IV
To be published in CV Materia Medica Vol. IV
Published as Monograph
Published as journal article in IJRH
|
|
CV project No.
|
Name of the drugs
|
Period of verification
|
Publication
|
|
2.
|
1. Agave Americana
2. Andrographis paniculata
3. Argemone Mexicana
4. Bacopa monniere
5. Chelone glabra
6. Clerodendron infortunatum
7. Coles aromaticus
8. Cornus circinata
9. Cuprum oxydatum nigrum
10. Ficus religiosa
11. Formic acid
12. Hydrocotyle asiatica
13. Juglans regia
14. Liatris spicata
15. Mimosa humilis
16. Ocimum sanctum
17. Paraffin
18. Pothos foetidus
19. Senega
20. Skookum chuck
21. Thymol
22. Thyroidinum
23. Tinospora cordifolia
|
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
2010-2014
|
To be published in CV materia medica vol. IV.
To be published in CV materia medica vol. IV.
To be published in CV materia medica vol. IV.
To be published in CV materia medica vol. IV.
To be published
To be published
To be published
To be published
To be published
To be published
Published as journal article in IJRH
To be published in CV material medica vol. IV
Published in CV material medica vol. II.
Published as a monograph.
QB vol 25 (1&2), 2003,pp. 13-14
Published in CV material medica vol. I.
QB vol. 26 Nop.1, 2004, pp. 17-21
To be published in CV material medica vol. IV
To be published
Published in CV Materia Medica Vol. III
Published as Monograph
Published as journal article in IJRH
To be published
To be published
To be published
To be published
To be published
To be published
To be published
|
|
CV project No.
|
Name of the drugs
|
Period of verification
|
Publication
|
|
{C}{C}3.{C}{C}
|
1 Allium sativa
2 Amoora rohituka
3 Asciapias currassavica
4 Avena sativa
5 Azathioprine
6 Buxus semperviens
7 Caesalpinia bonducella
8 Cardiospermum halic
9 Cyclosporine
10 Cynara scolymus
11 Foenimulum vulgare
12 Gymnema sylvestre
13 Hygrophilla spinosa
14 Magnolia grandiflora
15 Persea American
16 Psoralia corylifolia
|
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
2014-2018
|
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled
Concluding report being compiled.
Concluding report being compiled.
Concluding report being compiled
|
Concluded Studies under Clinical Research
{C}{C}A. {C}Open Clinical Trial –
{C}{C}· {C}Acute diarrhoeal diseases in children:A multicentricopen Clinical trial to evolve a group of efficacious homoeopathic medicines in the management of Acute diarrhoeal diseases in children wasinitiated in May, 2007 and concluded in September, 2008. 204 cases were screened & 189 were enrolled out of which 174 completed the study, against the target of 100.
{C}{C}· {C}Acute rhinitis in children:A multicentric open clinical trial to evolve a group of efficacious homoeopathic medicines in the management of Acute Rhinitis in Children was initiated in October,2005 and concluded June,2008.117 cases were screened, 107 cases were enrolled.
{C}{C}· {C}Urolithiasis: A Multicentre Observational study to ascertain the role of homoeopathic therapy in Urolithiasis was initiated in April, 2007 and concluded in January, 2010. 206 cases were screened, 50 cases were enrolled and 29 cases completed the study.
{C}{C}· {C}Chronic bronchitis: Simple and mucopurlent chronic bronchitis was initiated in April, 2007 and concluded in September, 2010. 172 cases were screened out of which 24 completed the study.
{C}{C}· {C}Chronic sinusitis:was initiated in July, 2008 and concluded in March, 2010. 187 cases were screened & 85 were enrolled out of which 68 completed the study.
{C}{C}· {C}Distress During Climatic Years(DDCY):Sepiain Menopausal Symptoms: A Multi-centre Randomized Double Blind Placebo Controlled Clinical Trial: Project started in May’12 & concluded in May’14.143 cases were screened & 22 were enrolled out of which 20 completed the study.
{C}{C}· {C}Influenza like illness: was initiated in February, 2013 and concluded in May, 2013. 38 cases were screened & 24 were enrolled out of which 24 completed the study
B. Pre-trial RCT studies:
{C}{C}· {C}Pre-diabetes:Pre-trial on Effects of Homoeopathic intervention in pre-diabetes (EHIP): A quasi experimental study. (Project initiated in November, 2013).
{C}{C}· {C}Dyslipidemia: Effect of individualized homoeopathic intervention in Dyslipidemia: An open label randomized controlled exploratory trial (Project initiated in February, 2014).
{C}{C}· {C}Hypertension:Effects of Homoeopathic Intervention in stage I essential hypertension: A randomised double blind, placebo controlled trial.(Project initiated in February, 2014.)
{C}{C}· {C}Susceptibility Study:Content validity of the questionnaire for assessment of susceptibility.(Project initiated in 10th January,2017 )
{C}{C}C. {C}Randomized Control Trial –
{C}{C}· {C}Chronic rhino-sinusitis: Double blind Triple Arm Randomized Control Trial on Chronic Rhinosinusitis: was initiated in May, 2012 and concluded in June, 2013. 136 cases were screened & 37 were enrolled out of which 31 completed the study.
{C}{C}· {C}Cervical spondylosis: To evaluate usefulness of homoeopathic treatment in Cervical Spondylosis pain management: was initiated in July, 2009 and concluded April, 2010. 46 cases were screened and 6 were enrolled.
{C}{C}· {C}Cervical spondylosis: Effect of Predefined homoeopathic medicines in Cervical Spondylosis Pain Management Multi centre Randomized Double Blind Placebo Controlled Clinical trial. Project initiated in April, 2012 & concluded in May, 2013. 89 cases were screened & 20 were enrolled.
{C}{C}· {C}Acute otitis media:A Comparative Randomized Controlled Trial of Homoeopathy &Allopathy in Acute Otitis Media & its recurrence in Children. (Project initiated in July, 2013& Concluded). Manuscript being drafted.
{C}{C}· {C}Benign Prostatic Hyperplasia: Homoeopathic Therapy for Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A randomized multicentric placebo controlled clinical trial . (Research article has been published in IJRH Volume 12, Issue 3, page 113-124).
{C}{C}· {C}Uterine fibroid:A Multicentric Randomized Clinical Trial of Homoeopathic Medicine in Lm Potency vis-a-vis Centesimal Potencies On Symptomatic Uterine Fibroids.(Research article published in IJRH)
{C}{C}· {C}Polycystic ovarian syndrome: Management of polycystic ovarian syndrome with homoeopathic intervention versus placebo -A randomized controlled pilot study. (Research article published in IJRH)
{C}{C}· {C}Breast Fibroadenoma: A Multi Centre single blind Randomized Placebo controlled Trial. (Data verification in process)
{C}{C}· {C}Lycopodium clavatum in Urolithiasis:A Randomized, Double Blind, Placebo Controlled Clinical Trial.(Manuscript being drafted)
{C}{C}· {C} Warts: Observational study of 10 dummy cases.
{C}{C}· {C}GERD :Published in IJRH
{C}{C}D. {C}{C}Drug Validation:Prognostic factor assessment of Homoeopathic medicines for cough (Pre-trial)(Project was initiated in January 2017 and concluded in February 2018. 280 cases were screened and 112 cases were enrolled)
.png)
.png)
